← Eichor
Condition: Medication Safety Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Medication Safety

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3 · 2 location(s) · Shanghai Yizhong Pharmaceutical Co., Ltd. · NCT06752811Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Phase N/A · 73 location(s) · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT03894228Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
NA · 1 location(s) · Ryazan State Medical University · NCT05933720Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
Phase N/A · 1 location(s) · Tongji Hospital · NCT07077473Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreat
Phase 1 · 1 location(s) · GeneCradle Inc · NCT05860569A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · 76 location(s) · Bayer · NCT04142437The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07307170Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute M
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT06484062From Administration of Oral Medicines by Nurses to Controlled Self-administration: Impact on Safety of Administration Du
NA · 1 location(s) · Centre Hospitalier de Valenciennes · NCT06639113A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Phase 1 · 7 location(s) · Shanghai Henlius Biotech · NCT07473726A Study of YL242 in Subjects With Advanced Solid Tumors
Phase 1/Phase 2 · 15 location(s) · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07197827A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
Phase 1 · 11 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07390955A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Hea
Phase 1 · 1 location(s) · Pfizer · NCT06994897A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid
Phase 1 · 12 location(s) · Bristol-Myers Squibb · NCT07077434Venoactive Drug Treatment of Pelvic Venous Disorders
Phase 3 · 1 location(s) · Pirogov Russian National Research Medical University · NCT06584799Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06782880A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07069569Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After R
Phase N/A · 1 location(s) · Liaoning Cancer Hospital & Institute · NCT06109454A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474A Study of EBC-129 in Advanced Solid Tumours
Phase 1 · 5 location(s) · EDDC (Experimental Drug Development Centre), A*STAR Research · NCT05701527A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · Akeso · NCT06929663Safer Still (Exploratory Project 3)
NA · 2 location(s) · Jeff Bridge · NCT06558409A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femor
NA · 3 location(s) · Balton Sp.zo.o. · NCT06734221Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Phase 1/Phase 2 · 1 location(s) · Luye Pharma Group Ltd. · NCT06731868R-3750 in Patients With Mild to Moderate Ulcerative Colitis
Phase 1 · 5 location(s) · Rise Therapeutics LLC · NCT05666960
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.